Cellular Dynamics to open California stem cell bank with $16m grant
This article was originally published in Scrip
Cellular Dynamics International (CDI) will open a center to create and bank human induced pluripotent stem cell (iPSC) lines for drug discovery and cell therapy development with $16 million in financing from the California Institute of Regenerative Medicine (CIRM).
You may also be interested in...
Aspen Neuroscience, Pandion and iTeos raised $70m, $80m and $125m, respectively. Also, Glide Healthcare closed a €416m ($450m) fund; ElevateBio, Kallyope and SutroVax reveal VC mega-rounds; and Dragonfly adds new funding to its partnering proceeds.
Approved in February as an on-demand remedy, Nurtec will be filed for migraine prevention after success in Phase III. It could be the first oral preventive therapy and first dual purpose migraine drug.
Clinical trials in a range of diseases continue to be impacted by concerns about patient safety and health care resources as the COVID-19 pandemic grows.